lixisenatide



lixisenatide

H1HH1G2GG2E3EE3G4GG4T5TT5F6FF6T7TT7S8SS8D9DD9L10LL10S11SS11K12KK12Q13QQ13M14MM14E15EE15E16EE16E17EE17A18AA18V19VV19R20RR20L21LL21F22FF22I23II23E24EE24W25WW25L26LL26K27KK27N28NN28G29GG29G30GG30P31PP31S32SS32S33SS33G34GG34A35AA35P36PP36P37PP37S38SS38K39KK39K40KK40K41KK41K42KK42K43KK43K44KK44

SMILES None
InChIKey XVVOERDUTLJJHN-IAEQDCLQSA-N
Sequence HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPSKKKKKK

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)


Bioactivities

lixisenatide

H1HH1G2GG2E3EE3G4GG4T5TT5F6FF6T7TT7S8SS8D9DD9L10LL10S11SS11K12KK12Q13QQ13M14MM14E15EE15E16EE16E17EE17A18AA18V19VV19R20RR20L21LL21F22FF22I23II23E24EE24W25WW25L26LL26K27KK27N28NN28G29GG29G30GG30P31PP31S32SS32S33SS33G34GG34A35AA35P36PP36P37PP37S38SS38K39KK39K40KK40K41KK41K42KK42K43KK43K44KK44

Drug properties

Molecular type Peptide
Physiological/Surrogate Surrogate
Approved drug Yes

Distribution across phases (no. indications)

Phase I 0
Phase II 1
Phase III 1
Phase IV 2


Sankey plot


Drug Information